OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

John Dong

John Dong

GenPhar Inc., USA

GenPhar Inc.,
USA

Biography

Dr. John Dong is President and CEO of GenPhar, Inc. Under John\'s leadership, GenPhar, Inc. has been focusing its efforts in developing vaccines and therapies against infectious diseases using a unique vaccine platform. Scientists at GenPhar have developed a number of multivalent vaccines against lethal viruses. John has established close collaborations with divisions of the United States Department of Defense (DoD) and National Institutes of Health (NIH). John\'s collaborations include: working with NIH to develop an HIV vaccine that induces both neutralizing and CTL responses; partnering with the US Army Research Institute of Infectious Diseases (USAMRIID) to develop a bivalent Ebola vaccine and a trivalent Marburg vaccine; and a joint effort with the US Navy Medical Research Center (NMRC) to develop a tetravalent dengue vaccine against all four serotypes of the dengue virus. John has also been leading the effort to develop commercial applications of the platform, including hepatitis, Influenza, RSV and a West Nile virus vaccine. Dr. Dong also has a long academic career. He obtained his medical degree at the Capital Medical Institute in Beijing, and his doctorate in molecular virology and immunology at the University of Alabama at Birmingham (UAB). He joined the faculty at UAB almost immediately after obtaining his Ph.D. with joint affiliations with both the Department of Physiology and Biophysics and the Gregory Fleming James Cystic Fibrosis Research Center. He then continued his successful academic career at the University of California-San Francisco (UCSF), and as a Professor in the Dept. of Microbiology and Immunology at the Medical University of South Carolina (MUSC). Dr. Dong is an expert in molecular virology and immunology and has published regularly in scientific journals such as the Journal of Virology, Human Gene Therapy, and the Proceedings of the National Academy of Sciences (PNAS). John served as the principal investigator on a number of federally funded grants and contracts, and his research has resulted in multiple patent awards

Research